BridgeBio Pharma Net Income 2018-2024 | BBIO

BridgeBio Pharma net income for the twelve months ending September 30, 2024 was $-0.439B, a 28.37% decline year-over-year.

  • BridgeBio Pharma annual net income for 2023 was $-0.643B, a 33.67% increase from 2022.
  • BridgeBio Pharma annual net income for 2022 was $-0.481B, a 14.46% decline from 2021.
  • BridgeBio Pharma annual net income for 2021 was $-0.563B, a 25.36% increase from 2020.

BridgeBio Pharma Net Income 2018-2024 | BBIO

  • BridgeBio Pharma annual net income for 2023 was $-0.643B, a 33.67% increase from 2022.
  • BridgeBio Pharma annual net income for 2022 was $-0.481B, a 14.46% decline from 2021.
  • BridgeBio Pharma annual net income for 2021 was $-0.563B, a 25.36% increase from 2020.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$24.9B
Dr Reddy's Laboratories (RDY)$12.6B
Bausch Health Cos (BHC)$2.8B
Supernus Pharmaceuticals (SUPN)$2.1B
Amphastar Pharmaceuticals (AMPH)$1.7B
Personalis (PSNL)$396M
Taysha Gene Therapies (TSHA)$314M
Assembly Biosciences (ASMB)$95M
Sol-Gel Technologies (SLGL)$25M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M